Variable | Measure | Data source |
---|---|---|
Sociodemographics | ||
Age, sex (assigned at birth), gender identity, hispanic ethnicity, race, housing status | N/A | Eligibility screener |
Marital status, income, education and insurance type | N/A | Baseline interview |
Mental health status and symptoms | ||
Prior psychiatric diagnosis (bipolar disorder or schizophrenia) | N/A | Eligibility screener |
Prior psychiatric hospitalization | ||
Depression (9 items) | Baseline interview 1-month follow-up | |
Anxiety (7 items) | ||
Social support | ||
Social support: family, friends, significant other (6 items; 2 each scale) | Modified multidimensional scale of perceived social support [111] | Baseline interview 1-month follow-up |
Medical symptoms/treatment | ||
Overdoses (lifetime, past 3 mos) | N/A | Baseline interview 1-month follow-up; EMR |
Primary and secondary diagnosis (inpatient stay) | Medical or mental health conditions as determined by the inpatient physician | EMR |
Pain intensity and duration | PEG [112] | Baseline interview 1-month follow-up |
Length of hospital stay | Days in hospital | EMR |
Substance use treatment history | ||
Ever used MOUD; times started an MOUD; type of MOUD; other treatment | N/A | Eligibility screener |
Recent substance use treatment utilization; opinions; consequences; stigma | ||
SUD treatment utilization | Adapted from National Survey on Drug Use and Health (NSDUH) [113] | Baseline interview 1-month follow-up (validation through follow-up with service provider) |
Healthcare utilization (ER, inpatient, outpatient) related to SUD (5 items) | Adapted from Global Appraisal of Individual Needs (GAIN) [114] | Baseline interview 1-month follow-up |
Opinions about MOUD | Adapted opinions about MAT (OAMAT) [115] | Baseline interview |
Severity of substance use | PROMIS | Baseline interview 1-month follow-up |
Patient experience of stigma | Adapted from Grosso et al. [116] | Baseline interview |
Patient experience of chronic illness care (11 items) | Patient Assessment of Chronic Illness Care (PACIC) [117] | 1-month Follow-up |
Criminal justice involvement | Locally developed | Baseline interview |
Intervention—related | ||
Intervention “dose”; exposure | Amount time spent with patient number of encounters with patient | START registry (Deidentified) |
Therapeutic alliance | Consumer Assessment of Healthcare Providers and Systems (CAHPS®) [118] | 1-month follow-up (START only) |
Satisfaction with START intervention | Locally developed | 1-month follow-up (START only) |